| Author [reference] | Year | Outcome evaluated | Technique used | Viability test | Islet origin/MSC tissue origin | Type of coculture | Time of coculture |
| Arzouni et al. [18] | 2017 | ISI | Radioimmunoassay | — | Human/hAD-MSC | Direct | 4 d | Arzouni et al. [19] | 2019 | ISI | Radioimmunoassay | — | Human, mouse/hAD-MSC, hBM-MSC, mAD-MSC, mKidney-MSC | Direct | 1 d/2 d/3 d | Chen et al. [38] | 2013 | Viability, ISI | Radioimmunoassay | AO/PI | Rat/rBM-MSC | Direct | 2 w | Davis et al. [27] | 2012 | ISI | ELISA | — | Mouse/mBM-MSC | Encapsulation | 7 d | Duprez et al. [12] | 2011 | ISI | ELISA | — | Human/hBM-MSC | Direct | 2 d | Jun et al. [28] | 2014 | ISI, viability | ELISA | Calcein AM/ethidium homodimer-1 | Rat/rAD-MSC | Encapsulation | 7 d/14 d | Jung et al. [13] | 2011 | Viability, VEGF, TNF-α, ISI | ELISA | FDA/PI | Rat/rBM-MSC | Indirect/direct | 1 w/4 w | Karaoz et al. [29] | 2010 | Viability, IL-6, ISI | ELISA | FDA/PI | Rat/rBM-MSC | Indirect | 2 w | Karaoz et al. [11] | 2011 | Insulin | ELISA | | Rat/rBM-MSC | Direct | 16 d | Kerby et al. [30] | 2013 | ISI | Radioimmunoassay | | Mouse/mKidney-MSC | Encapsulation | 3 d | Kono et al. [31] | 2014 | Viability, VEGF | — | EH 1/calcein AM | Mouse/hAD-MSC | Indirect | 6 d | Lu et al. [33] | 2010 | ISI | ELISA | — | Rat/rBM-MSC | Direct | 3 d/4 d | Ayenehdeh et al. [20] | 2017 | Insulin | ELISA | — | Mouse/mAD-MSC | Encapsulation | — | Montanari et al. [15] | 2017 | ISI | ELISA | — | Human/hBM-MSC | Indirect/direct | 3 d | Park et al. [25] | 2009 | ISI, VEGF, IL-6, TNF-α | ELISA | — | Human/hBM-MSC, hUCB-MSC | Indirect | 2 d | Park et al. [26] | 2010 | ISI, viability | ELISA | AO/PI | Mouse/hUCB-MSC | Indirect | 2 d | Rackham et al. [14] | 2013 | ISI | Radioimmunoassay | — | Mouse/mKidney-MSC | Indirect/direct | 3 d | Rackham et al. [34] | 2014 | ISI | Radioimmunoassay | — | Mouse/mAD-MSC | Direct | 3 d | Rackham et al. [35] | 2016 | ISI | Radioimmunoassay | | Mouse/mAD-MSC | Direct | 3 d | Scuteri et al. [16] | 2014 | Viability, insulin | ELISA | Calcein AM | Rat/rBM-MSC | Indirect/direct | 1 w | Yamada et al. [36] | 2014 | Viability, IL-6, VEGF, TNF-α, insulin | ELISA | Trypan blue staining | Pig/hAD-MSC | Indirect | 2 d | Yoshimatsu et al. [37] | 2013 | Viability, ISI | ELISA | Syto-Green/EB | Rat/rBM-MSC | Direct/encapsulation | 3 d | Yoshimatsu et al. [9] | 2015 | Viability, ISI, insulin | ELISA | Syto-Green/EB | Mouse/mBM-MSC | Direct | 1 d/4 d | Ren et al. [21] | 2019 | — | — | — | Mouse/mAD-MSC | Cotransplantation | — |
|
|